Cypress Capital Group acquired a new position in shares of Humana Inc (NYSE:HUM) during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 1,017 shares of the insurance provider’s stock, valued at approximately $248,000.

A number of other hedge funds have also recently modified their holdings of HUM. WFG Advisors LP grew its position in shares of Humana by 4.5% in the 2nd quarter. WFG Advisors LP now owns 469 shares of the insurance provider’s stock valued at $113,000 after buying an additional 20 shares during the last quarter. Fieldpoint Private Securities LLC bought a new stake in shares of Humana in the 3rd quarter valued at about $115,000. Acrospire Investment Management LLC bought a new stake in shares of Humana in the 2nd quarter valued at about $120,000. Northwestern Mutual Wealth Management Co. grew its position in shares of Humana by 139.5% in the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 558 shares of the insurance provider’s stock valued at $134,000 after buying an additional 325 shares during the last quarter. Finally, Fiduciary Trust Co. bought a new stake in shares of Humana in the 2nd quarter valued at about $135,000. Institutional investors and hedge funds own 94.19% of the company’s stock.

Humana Inc (NYSE:HUM) opened at $256.24 on Thursday. The stock has a market capitalization of $36,377.89, a PE ratio of 21.73, a PEG ratio of 1.75 and a beta of 0.88. The company has a debt-to-equity ratio of 0.35, a current ratio of 1.61 and a quick ratio of 1.61. Humana Inc has a 52 week low of $186.25 and a 52 week high of $264.56.

Humana (NYSE:HUM) last announced its quarterly earnings data on Wednesday, November 8th. The insurance provider reported $3.39 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.27 by $0.12. The company had revenue of $13.28 billion for the quarter, compared to the consensus estimate of $13.41 billion. Humana had a return on equity of 15.99% and a net margin of 3.49%. The firm’s revenue was down 3.0% compared to the same quarter last year. During the same period in the previous year, the business earned $3.18 EPS. sell-side analysts predict that Humana Inc will post 11.63 earnings per share for the current fiscal year.

The company also recently declared a quarterly dividend, which will be paid on Friday, January 26th. Investors of record on Friday, December 29th will be paid a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a yield of 0.62%. The ex-dividend date is Thursday, December 28th. Humana’s dividend payout ratio (DPR) is currently 12.59%.

HUM has been the topic of a number of analyst reports. BMO Capital Markets upped their price target on Humana from $290.00 to $300.00 and gave the company an “outperform” rating in a research report on Friday, November 10th. ValuEngine upgraded Humana from a “hold” rating to a “buy” rating in a research report on Friday, September 1st. Royal Bank of Canada reiterated a “sector perform” rating and issued a $242.00 price target (down previously from $245.00) on shares of Humana in a research report on Thursday, November 9th. Credit Suisse Group reduced their price target on Humana from $256.00 to $246.00 and set a “neutral” rating on the stock in a research report on Friday, November 10th. Finally, Zacks Investment Research lowered Humana from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, October 17th. Twelve equities research analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company’s stock. Humana presently has a consensus rating of “Hold” and a consensus price target of $256.30.

TRADEMARK VIOLATION WARNING: This piece of content was first posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this piece of content on another site, it was illegally copied and reposted in violation of U.S. and international trademark and copyright legislation. The correct version of this piece of content can be accessed at https://www.thecerbatgem.com/2017/12/14/cypress-capital-group-takes-248000-position-in-humana-inc-hum.html.

About Humana

Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc (NYSE:HUM).

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Receive News & Stock Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related stocks with our FREE daily email newsletter.